Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001010207-10-000052
Filing Date
2010-02-16
Accepted
2010-02-16 16:58:21
Documents
1
Group Members
BRIAN J. STARK

Document Format Files

Seq Description Document Type Size
1 CALYPTE BIOMEDICAL CORPORATION SCHEDULE 13G.A.8 sch13ga8cbmc2010216.txt SC 13G/A 11114
  Complete submission text file 0001010207-10-000052.txt   12882
Mailing Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588
Business Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588 9257307200
CALYPTE BIOMEDICAL CORP (Subject) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50235 | Film No.: 10609157
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 3600 SOUTH LAKE DRIVE ST. FRANCIS WI 53235
Business Address
Roth Michael Anthony (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G/A